)
eXoZymes (EXOZ) investor relations material
eXoZymes Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Marked the one-year anniversary of IPO, transitioning from scientific breakthrough to a technology platform targeting high-value biomanufacturing markets and scalable, sustainable chemical production for pharmaceuticals, fuels, materials, and food additives.
Focused on three core product opportunities: NCT (metabolic health), non-intoxicating cannabinoids, and Sandeline (from sandalwood oil), each with dual nutraceutical and pharmaceutical potential.
Operates as a single reportable segment, with all business activities managed on a consolidated basis.
Emphasized a capital-light, value-driven business model, leveraging partnerships and non-dilutive funding.
Hosted a Q3 2025 update to review recent developments, ongoing initiatives, and anticipated milestones.
Financial highlights
Cash and cash equivalents at end of September 2025 were $5.1 million, sufficient to fund operations into Q2 2026.
Net loss for nine months ended September 30, 2025 was $6.5 million, up 61.6% year-over-year; Q3 net loss was $2.29 million.
Operating expenses increased by $0.9 million year-over-year in Q3, mainly due to expanded R&D and leadership hires.
Working capital at quarter-end was $4.4 million, down from $9.5 million at December 31, 2024.
No revenue recognized; company remains pre-commercial.
Outlook and guidance
Plans to scale up NCT production and commercialize through spinout NCTX, targeting both direct-to-consumer and retail channels.
Management believes current working capital is sufficient for near-term operations but expresses substantial doubt about long-term ability to continue as a going concern without additional funding.
Exploring additional capital raising but committed to maintaining a capital-light approach and minimizing shareholder dilution.
Management expects further development, validation, and regulatory processes before commercialization.
Plans to seek further grants, equity, or debt financing to support ongoing R&D and commercialization efforts.
Next eXoZymes earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage